JENNIFER BUNCH: Open Payments
NPI 1962134999 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 22 payments from 8 companies in 2025. Trend: 2023 $411 · 2024 $452 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $166 |
| Esperion Therapeutics, Inc. | 1 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| Abbott Laboratories | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Amgen Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: LEQVIO, NEXLETOL, EVKEEZA, CARDIOMEMS, LifeVest, REPATHA, ELIQUIS, CAMZYOS.
Industry payments across LA — which companies pay providers there.
